Published on: 2026-09-25
Source: Moscow Government – Правительства Москвы –
An important disclaimer is at the bottom of this article.
In Moscow, the production of advanced, high-tech medicines is growing medical materials and products. About this in his channel on in the messenger “Max” said Sergey Sobyanin.
“In particular, capital city enterprises increased the production of drugs for the treatment of respiratory organs by 29.4 percent in the first half of the year, medicines for the nervous system by 9.1 percent, and drugs affecting hematopoiesis and blood by 22.2 percent,” noted the Mayor of Moscow.
Source: Sergey Sobyanin’s channel on in the “Max” messenger
A key platform for industry development — special economic zone “Technopolis Moscow.” The largest in the country is formed there pharmaceutical cluster. 10 out of 14 companies are already producing innovative medicines and medical devices.
“The city supports manufacturers with tax benefits, financial instruments, and ready infrastructure,” Sergei Sobyanin specified.
Thus, Moscow helps enterprises to expand capacity, implement new technologies, and produce more drugs in demand in various regions of Russia.
A large-scale project is presented on the portal mos.ru
special project, dedicated to the development of key sectors in Moscow. Among them are transport, industry, healthcare, education, sports, and the construction sector. The special project helps to learn how the capital has changed over the past years, which initiatives aimed at making the lives of citizens even more comfortable are currently being implemented, and what awaits Moscow and its residents in the near future.
On the project page
“Economics” You can learn about the main indicators of the capital’s economic growth, its drivers and prospects, as well as which indicators can be achieved in the current year.
Stay promptly informed of the main news on the official channels of the city of Moscow in messengers “Max” and Telegram.
Please note; This information is raw content obtained directly from the source. It is an accurate account of what the source claims and does not necessarily reflect the position of MIL-OSI or its clients.